Attached you will find an invite for the following meeting; forwarding on
behalf of PCORnet's Front Door:
Network Collaboration Opportunity: Comparing Effectiveness of MS DMTs
CDRN Network Navigators,
Please forward this calendar invite for a 30 min Q&A session regarding Robert
McBurney and the MS PPRN's request for CDRN collaborators on their study
entitled “Comparing Effectiveness of MS DMTs in a Real-World Study” to those in
your network who may be interested in collaborating. The call-in and WebEx
information follow.
To see the full network collaborator request, please go here:
https://pcornet.imeetcentral.com/p/aQAAAAAC2-QK<https://www.google.com/url?q=https%3A%2F%2Fpcornet.imeetcentral.com%2Fp%2FaQAAAAAC2-QK&sa=D&usd=2&usg=AFQjCNFw0g6-8neICKhanLCVNxAN_Z_SWA>.
Network Collaborator Request: Comparing Effectiveness of MS DMTs
Thursday, October 20, 2016
1:00 pm | Eastern Daylight Time (New York, GMT-04:00) | 30 mins
Meeting number (access code): 735 301 706
Meeting password: 1234
https://dukemed.webex.com/dukemed/j.php?MTID=m26670387d0bfe974e97b82e619f67c09<https://www.google.com/url?q=https%3A%2F%2Fdukemed.webex.com%2Fdukemed%2Fj.php%3FMTID%3Dm26670387d0bfe974e97b82e619f67c09&sa=D&usd=2&usg=AFQjCNEmWDymY2UrOJJ97H9PWYuT-53sPw>
Join by phone
1-855-244-8681 Call-in toll-free number (US/Canada)
1-650-479-3207 Call-in toll number (US/Canada)
Global call-in numbers | Toll-free calling restrictions
________________________________
From: Brittany Zschoche
Sent: Friday, October 14, 2016 11:14 AM
To: 'Lindsay Cowell'; 'Marc Drezner'; 'Greenlee, Robert T PHD';
'[email protected]'; '[email protected]'; '[email protected]'; 'Bradley H
Pollock'; 'Parker, Jerry C.'; '[email protected]'; 'Barnett, William Kinne';
'[email protected]'; 'Chrischilles, Elizabeth A'; '[email protected]'; 'Umberto
Tachinardi'; ''[email protected]' ([email protected])';
[email protected]; [email protected]
Cc: Russ Waitman; Steve Fennel
Subject: FW: IMMEDIATE NEED: CDRN Collaborators for MS Study
GPC Site PIs, PMs, PEOs:
Please see the attached request. If you and/or a colleague at your site are
interested in the collaboration, please do the following:
1. Complete the Front Door intake form linked below
2. Reply to this email and let Brittany Zschoche know who completed the
intake form
Thank you,
Brittany Zschoche
________________________________
From: PCORnet Front Door [[email protected]]
Sent: Wednesday, October 12, 2016 8:41 AM
To: [email protected]; [email protected]; [email protected];
Brittany Zschoche; [email protected]; [email protected];
[email protected]; [email protected]; [email protected]; Mark
Hanson; [email protected]; [email protected]; [email protected];
pSCANNER Project; [email protected]; Steve Fennel; [email protected];
[email protected]; TaJuana Chisholm; [email protected];
Black, Lesa R; [email protected]; [email protected]; [email protected];
[email protected]
Subject: IMMEDIATE NEED: CDRN Collaborators for MS Study
CDRN Network Navigators and proposed Autoimmune Disease CRG Leads,
Robert McBurney and his team within the MS-PPRN are seeking CDRNs to assist
with feasibility, CDM data request, participant/patient recruitment/enrollment,
participant/patient engagement, investigator expertise, and participant/patient
expertise on a prospective observational study with the proposed title
“Comparing Effectiveness of MS DMTs in a Real-World Study”. More details are
attached with further explanation around each type of collaboration they are
seeking.
If you or anyone within your network is interested in collaborating on this
study, please fill out the response form
here<https://frontdoor.dcri.org/Lists/NCR%20Response/Item/newifs.aspx?List=444fd35b-1b2d-4ed0-a4dc-7021d67843bd&Source=https%3A%2F%2Ffrontdoor%2Edcri%2Eorg%2FLists%2FNCR%2520Response%2FAllItems%2Easpx&RootFolder=&Web=71672852-2f2a-4f6e-b7b6-63e33ed408ba&isDlg=1>.
The deadline for responses is ASAP but before 10/21/2016 as the LOI for this
study is due November 1.
Thank you,
PCORnet Front Door
[email protected]<mailto:[email protected]>
--- Begin Message ---
BEGIN:VCALENDAR
PRODID:-//Google Inc//Google Calendar 70.9054//EN
VERSION:2.0
CALSCALE:GREGORIAN
METHOD:REQUEST
BEGIN:VEVENT
DTSTART:20161020T170000Z
DTEND:20161020T173000Z
DTSTAMP:20161014T180041Z
ORGANIZER;[email protected]:mailto:[email protected]
UID:[email protected]
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;[email protected];X-NUM-GUESTS=0:mailto:[email protected]
op.edu
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;[email protected];X-NUM-GUESTS=0:mailto:[email protected]
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;[email protected];X-NUM-GUESTS=0:mailto:[email protected]
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=ACCEPTED;RSVP=TRUE
;[email protected];X-NUM-GUESTS=0:mailto:[email protected]
arvard.edu
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;CN=Mark Hanson;X-NUM-GUESTS=0:mailto:[email protected]
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;[email protected];X-NUM-GUESTS=0:mailto:[email protected]
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;[email protected];X-NUM-GUESTS=0:mailto:[email protected]
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;[email protected];X-NUM-GUESTS=0:mailto:cecilia.dobi@tuh
s.temple.edu
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;[email protected];X-NUM-GUESTS=0:mailto:[email protected]
du
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=ACCEPTED;RSVP=TRUE
;[email protected];X-NUM-GUESTS=0:mailto:[email protected]
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;[email protected];X-NUM-GUESTS=0:mailto:[email protected]
ah.edu
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;[email protected];X-NUM-GUESTS=0:mailto:[email protected]
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;[email protected];X-NUM-GUESTS=0:mailto:[email protected]
du
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=ACCEPTED;RSVP=TRUE
;[email protected];X-NUM-GUESTS=0:mailto:[email protected]
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;[email protected];X-NUM-GUESTS=0:mailto:[email protected]
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;[email protected];X-NUM-GUESTS=0:mailto:[email protected]
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=ACCEPTED;RSVP=TRUE
;[email protected];X-NUM-GUESTS=0:mailto:[email protected]
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;[email protected];X-NUM-GUESTS=0:mailto:[email protected]
du
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;[email protected];X-NUM-GUESTS=0:mailto:stephanie.r.prau
[email protected]
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;[email protected];X-NUM-GUESTS=0:mailto:[email protected]
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;[email protected];X-NUM-GUESTS=0:mailto:[email protected]
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;CN=pSCANNER Project;X-NUM-GUESTS=0:mailto:[email protected]
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;[email protected];X-NUM-GUESTS=0:mailto:rmcburney@accel
eratedcure.org
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;[email protected];X-NUM-GUESTS=0:mailto:jennifer.eisinger@
duke.edu
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;[email protected];X-NUM-GUESTS=0:mailto:lesa.black@vanderbi
lt.edu
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;[email protected];X-NUM-GUESTS=0:mailto:[email protected]
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;[email protected];X-NUM-GUESTS=0:mailto:adrian.hernandez@du
ke.edu
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;[email protected];X-NUM-GUESTS=0:mailto:[email protected]
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;CN=Duke/HPHCI/GA PMO;X-NUM-GUESTS=0:mailto:[email protected]
rg
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;[email protected];X-NUM-GUESTS=0:mailto:sloud@acceleratedcu
re.org
ATTENDEE;CUTYPE=INDIVIDUAL;ROLE=REQ-PARTICIPANT;PARTSTAT=NEEDS-ACTION;RSVP=
TRUE;CN=Sharon Terry;X-NUM-GUESTS=0:mailto:[email protected]
CREATED:20161014T175630Z
DESCRIPTION:CDRN Network Navigators\,\n\nPlease forward this calendar invit
e for a 30 min Q&A session regarding Robert McBurney and the MS PPRN's requ
est for CDRN collaborators on their study entitled “Comparing Effectiveness
of MS DMTs in a Real-World Study” to those in your network who may be inte
rested in collaborating. The call-in and WebEx information follow.\n\nTo se
e the full network collaborator request\, please go here: https://pcornet.i
meetcentral.com/p/aQAAAAAC2-QK. \n\nNetwork Collaborator Request: Comparing
Effectiveness of MS DMTs \nThursday\, October 20\, 2016 \n1:00 pm | East
ern Daylight Time (New York\, GMT-04:00) | 30 mins \n\nMeeting number (ac
cess code): 735 301 706 \nMeeting password: 1234\n\nhttps://dukemed.webex.c
om/dukemed/j.php?MTID=m26670387d0bfe974e97b82e619f67c09\n \nJoin by phone\n
1-855-244-8681 Call-in toll-free number (US/Canada)\n1-650-479-3207 Call-in
toll number (US/Canada)\nGlobal call-in numbers | Toll-free calling rest
rictions\n\n\nView your event at https://www.google.com/calendar/event?acti
on=VIEW&eid=ZXA3bTkxNDlpM2dlOGgxdGNxNmpncmpkN2cgYnpzY2hvY2hlQGt1bWMuZWR1&to
k=MjEjZnJvbnRkb29yQHBjb3JuZXQub3JnZTM0NzcwNjIyNDBkMjI4NGUzMGIxODNkNDBjZGEwO
TRlNDQ1N2VmYw&ctz=America/New_York&hl=en.
LAST-MODIFIED:20161014T180040Z
LOCATION:Call in: 1-855-244-8681 AC: 735 301 706
SEQUENCE:0
STATUS:CONFIRMED
SUMMARY:Network Collaboration Opportunity: Comparing Effectiveness of MS DM
Ts
TRANSP:OPAQUE
END:VEVENT
END:VCALENDAR
invite.ics
Description: application/ics
--- End Message ---
_______________________________________________
Gpc-engagement mailing list
[email protected]
http://listserv.kumc.edu/mailman/listinfo/gpc-engagement
